Friday, May 1, 2026

Real Madrid Clinches Kylian Mbappe for a Whopping €150 Million Deal!

Kylian Mbappé's move to Spain's Real Madrid is imminent. BBC, known for its credibility, has confirmed Mbappé's entry.

From ResNet to AlexNet—The Blueprint for 21st Century AI Revolution

The most cited paper of the 21st century is Microsoft's ResNet, pivotal for AI advancements like AlphaGo and ChatGPT.

Lunit’s AI Innovations: How a Meeting with France’s SGPI Could Transform Healthcare

Lunit discusses collaboration with France's SGPI to enhance medical AI technology in public healthcare, aligning with a strategic partnership.

Tag: Wegovy

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Novo Nordisk’s Oral Wegovy Tops 3,000 Prescriptions in Its First Week—A Challenge to Injectable GLP-1s

Novo Nordisk's Wegovy oral treatment exceeds 3,000 prescriptions in its debut week, signaling a shift towards oral obesity medications.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.